The epidemiology of Anaerococcus lactolyticus is not very well known, but some studies have suggested that it is a common and opportunistic pathogen that can cause various infections in humans.
Some of the epidemiological aspects of Anaerococcus lactolyticus are:
Anaerococcus lactolyticus is a Gram-positive, anaerobic, saccharolytic bacterium that belongs to the family Peptoniphilaceae.
Anaerococcus lactolyticus can be found in the human body as part of the normal microbiota, especially in the skin, oral cavity, vagina, and feces.
Anaerococcus lactolyticus can also participate in polymicrobial infections of various sites, such as diabetic foot ulcers, pressure ulcers, urinary tract infections, ovarian abscesses, pleural empyema, blood infections, and soft tissue infections.
Anaerococcus lactolyticus can be isolated from clinical specimens, such as pus, blood, urine, sputum, and tissue biopsies.
Anaerococcus lactolyticus has at least two serotypes based on the presence or absence of a capsular polysaccharide antigen. The capsular antigen may influence the virulence and pathogenicity of the bacterium, as well as its susceptibility to antibiotics and host immune response.
Anaerococcus lactolyticus is generally susceptible to penicillins but resistant to tetracycline, erythromycin, and clindamycin. However, antimicrobial resistance patterns may vary depending on the geographic region and the type of infection.
Anaerococcus lactolyticus is classified as a risk group 1 bacterium according to the TRBA 466 classification, which means that it is unlikely to cause human disease or pose a hazard to workers. However, it may still cause infections in immunocompromised or debilitated individuals.
Kingdom: Bacteria
Phylum: Bacillota
Class: Clostridia
Order: Eubacteriales
Family: Peptoniphilaceae
Genus: Anaerococcus
Species: A. lactolyticus
The structure and characteristics of Anaerococcus lactolyticus can be summarized in five key points:
Gram-positive Bacterium: Anaerococcus lactolyticus possesses a thick layer of peptidoglycan in its cell wall, classifying it as a Gram-positive bacterium. Its characteristic allows it to retain the purple stain when subjected to the Gram staining method.
Strictly Anaerobic Nature: Anaerococcus lactolyticus is obligately anaerobic, meaning it can only thrive in environments devoid of oxygen. The presence of oxygen can be detrimental and potentially lethal to this bacterium.
Saccharolytic Metabolism: This bacterium is saccharolytic, indicating its ability to metabolize sugars and other carbohydrates as energy sources. Because of this metabolic activity, Anaerococcus lactolyticus produces various organic acids as by-products.
Coccal Morphology: Anaerococcus lactolyticus exhibits a coccal morphology characterized by its spherical or oval shape. Depending on the specific strain or species, it can arrange itself in pairs, tetrads, short chains, or irregular formations. The diameter of its cells typically ranges from 0.5 to 2 micrometers.
Serotypes with Capsular Antigens: Anaerococcus lactolyticus demonstrates at least two serotypes that can be distinguished based on the presence or absence of a capsular polysaccharide antigen on its surface. This capsular antigen can affect the bacterium’s virulence, pathogenicity, antibiotic susceptibility, and interaction with the host immune response.
It can be found in the human body as part of the normal microbiota. Still, it can also cause infections in various sites, such as diabetic foot ulcers, urinary tract infections, and ovarian abscesses.
The antigenic types of Anaerococcus lactolyticus need to be well-studied. Still, some research has suggested that it has at least two serotypes based on the presence or absence of a capsular polysaccharide antigen. The capsular antigen may play a role in the virulence and pathogenicity of this bacterium, as well as its susceptibility to antibiotics and host immune response. However, more studies are needed to confirm and characterize the antigenic types of Anaerococcus lactolyticus and their clinical significance.
The pathogenesis of Anaerococcus lactolyticus is not well understood, but some possible mechanisms have been suggested based on its characteristics and associations with various infections. Here are some of them:
Anaerococcus lactolyticus is a saccharolytic bacterium that can ferment glucose and other carbohydrates to produce lactic acid and other organic acids.
Because of these acids, the pH of the local environment creates favorable conditions for the growth of other anaerobic bacteria, such as Peptoniphilus, Finegoldia, and Prevotella.
It can lead to polymicrobial infections and biofilm formation, impairing wound healing and increasing antibiotic resistance.
Anaerococcus lactolyticus can also produce hydrogen sulfide, a toxic gas that can damage the host tissues and cells. Hydrogen sulfide can also inhibit the oxidative burst of neutrophils, which are critical immune cells that kill bacteria. It can impair the host’s defense against infection and inflammation.
Anaerococcus lactolyticus can adhere to epithelial proteins in the extracellular matrix, which includes fibronectin and collagen, and cells involved in tissue repair and integrity. It can facilitate its invasion and colonization of the host tissues, especially in the presence of foreign bodies or damaged surfaces.
Anaerococcus lactolyticus can trigger inflammatory responses in the host by activating toll-like receptors (TLRs), which recognize bacterial components and initiate immune signaling pathways. It can produce Interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha), two pro-inflammatory cytokines, which can cause tissue damage and systemic symptoms.
The host defenses of Anaerococcus lactolyticus are poorly understood, but some studies have suggested that the bacterium can evade or resist the immune system in various ways. For example:
Anaerococcus lactolyticus can produce a capsular polysaccharide antigen that may protect it from phagocytosis and complement-mediated killing.
Anaerococcus lactolyticus can form biofilms that may enhance its survival and persistence in chronic wounds and diabetic foot ulcers1.
Anaerococcus lactolyticus can secrete proteases that may degrade host proteins and impair wound healing.
Anaerococcus lactolyticus can modulate the inflammatory response by promoting the production of cytokines that cause inflammation, like IL-6 and IL-8, and suppressing the anti-inflammatory cytokine IL-10.
However, more research is needed to elucidate the mechanisms and factors involved in the host defenses of Anaerococcus lactolyticus and its interactions with the host immune system.
The bacteria Anaerococcus lactolyticus belongs to the Peptoniphilaceae family.
It is found in the human microbiome and is associated with various infections.
Some of the clinical manifestations of Anaerococcus lactolyticus are:
Diabetic foot and pressure ulcers: Anaerococcus lactolyticus and Anaerococcus vaginalis can be dominant species in these chronic wounds, forming biofilms and resisting antibiotic treatment.
Urinary tract infections: Anaerococcus lactolyticus can participate in polymicrobial urinary tract infections, especially in renal transplant recipients with impaired immunity and urinary catheters.
Ovarian abscesses: Anaerococcus lactolyticus can be isolated from ovarian abscesses, which are collections of pus in the ovaries caused by bacterial infection.
Knee arthritis: Anaerococcus lactolyticus can be involved in septic arthritis of the knee, which is a painful joint inflammation due to bacterial invasion.
Methods for diagnosing Anaerococcus lactolyticus include:
Culture: Grow on enriched blood agar under anaerobic conditions, forming small white colonies.
Biochemical Tests: Use kits like Rapid ID 32A or API ZYM to test for reactions like glucose fermentation and enzyme activities.
Molecular Methods: Use PCR to amplify specific DNA regions (e.g., 16S rRNA gene) or sequencing to compare DNA sequences with known bacteria. MALDI-TOF MS can analyze protein profiles for identification.
The prevention of Anaerococcus lactolyticus infections depends on the type and site of infection, as well as the individual’s risk factors and underlying conditions. However, some general measures that can be taken are:
upholding hygienic and sanitary standards, such as washing hands, cleaning wounds, and changing dressings regularly.
Avoiding or minimizing the use of foreign bodies or devices that can introduce or harbor bacteria, such as urinary catheters, intravenous lines, or prosthetic joints.
Seeking medical attention promptly if symptoms of infection occur, such as fever, pain, swelling, redness, or discharge.
Taking antibiotics as prescribed by a doctor and completing the entire course of treatment.
Following the doctor’s advice on wound care, diabetes management, or other relevant conditions affecting the healing process and the immune system.
The epidemiology of Anaerococcus lactolyticus is not very well known, but some studies have suggested that it is a common and opportunistic pathogen that can cause various infections in humans.
Some of the epidemiological aspects of Anaerococcus lactolyticus are:
Anaerococcus lactolyticus is a Gram-positive, anaerobic, saccharolytic bacterium that belongs to the family Peptoniphilaceae.
Anaerococcus lactolyticus can be found in the human body as part of the normal microbiota, especially in the skin, oral cavity, vagina, and feces.
Anaerococcus lactolyticus can also participate in polymicrobial infections of various sites, such as diabetic foot ulcers, pressure ulcers, urinary tract infections, ovarian abscesses, pleural empyema, blood infections, and soft tissue infections.
Anaerococcus lactolyticus can be isolated from clinical specimens, such as pus, blood, urine, sputum, and tissue biopsies.
Anaerococcus lactolyticus has at least two serotypes based on the presence or absence of a capsular polysaccharide antigen. The capsular antigen may influence the virulence and pathogenicity of the bacterium, as well as its susceptibility to antibiotics and host immune response.
Anaerococcus lactolyticus is generally susceptible to penicillins but resistant to tetracycline, erythromycin, and clindamycin. However, antimicrobial resistance patterns may vary depending on the geographic region and the type of infection.
Anaerococcus lactolyticus is classified as a risk group 1 bacterium according to the TRBA 466 classification, which means that it is unlikely to cause human disease or pose a hazard to workers. However, it may still cause infections in immunocompromised or debilitated individuals.
Kingdom: Bacteria
Phylum: Bacillota
Class: Clostridia
Order: Eubacteriales
Family: Peptoniphilaceae
Genus: Anaerococcus
Species: A. lactolyticus
The structure and characteristics of Anaerococcus lactolyticus can be summarized in five key points:
Gram-positive Bacterium: Anaerococcus lactolyticus possesses a thick layer of peptidoglycan in its cell wall, classifying it as a Gram-positive bacterium. Its characteristic allows it to retain the purple stain when subjected to the Gram staining method.
Strictly Anaerobic Nature: Anaerococcus lactolyticus is obligately anaerobic, meaning it can only thrive in environments devoid of oxygen. The presence of oxygen can be detrimental and potentially lethal to this bacterium.
Saccharolytic Metabolism: This bacterium is saccharolytic, indicating its ability to metabolize sugars and other carbohydrates as energy sources. Because of this metabolic activity, Anaerococcus lactolyticus produces various organic acids as by-products.
Coccal Morphology: Anaerococcus lactolyticus exhibits a coccal morphology characterized by its spherical or oval shape. Depending on the specific strain or species, it can arrange itself in pairs, tetrads, short chains, or irregular formations. The diameter of its cells typically ranges from 0.5 to 2 micrometers.
Serotypes with Capsular Antigens: Anaerococcus lactolyticus demonstrates at least two serotypes that can be distinguished based on the presence or absence of a capsular polysaccharide antigen on its surface. This capsular antigen can affect the bacterium’s virulence, pathogenicity, antibiotic susceptibility, and interaction with the host immune response.
It can be found in the human body as part of the normal microbiota. Still, it can also cause infections in various sites, such as diabetic foot ulcers, urinary tract infections, and ovarian abscesses.
The antigenic types of Anaerococcus lactolyticus need to be well-studied. Still, some research has suggested that it has at least two serotypes based on the presence or absence of a capsular polysaccharide antigen. The capsular antigen may play a role in the virulence and pathogenicity of this bacterium, as well as its susceptibility to antibiotics and host immune response. However, more studies are needed to confirm and characterize the antigenic types of Anaerococcus lactolyticus and their clinical significance.
The pathogenesis of Anaerococcus lactolyticus is not well understood, but some possible mechanisms have been suggested based on its characteristics and associations with various infections. Here are some of them:
Anaerococcus lactolyticus is a saccharolytic bacterium that can ferment glucose and other carbohydrates to produce lactic acid and other organic acids.
Because of these acids, the pH of the local environment creates favorable conditions for the growth of other anaerobic bacteria, such as Peptoniphilus, Finegoldia, and Prevotella.
It can lead to polymicrobial infections and biofilm formation, impairing wound healing and increasing antibiotic resistance.
Anaerococcus lactolyticus can also produce hydrogen sulfide, a toxic gas that can damage the host tissues and cells. Hydrogen sulfide can also inhibit the oxidative burst of neutrophils, which are critical immune cells that kill bacteria. It can impair the host’s defense against infection and inflammation.
Anaerococcus lactolyticus can adhere to epithelial proteins in the extracellular matrix, which includes fibronectin and collagen, and cells involved in tissue repair and integrity. It can facilitate its invasion and colonization of the host tissues, especially in the presence of foreign bodies or damaged surfaces.
Anaerococcus lactolyticus can trigger inflammatory responses in the host by activating toll-like receptors (TLRs), which recognize bacterial components and initiate immune signaling pathways. It can produce Interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha), two pro-inflammatory cytokines, which can cause tissue damage and systemic symptoms.
The host defenses of Anaerococcus lactolyticus are poorly understood, but some studies have suggested that the bacterium can evade or resist the immune system in various ways. For example:
Anaerococcus lactolyticus can produce a capsular polysaccharide antigen that may protect it from phagocytosis and complement-mediated killing.
Anaerococcus lactolyticus can form biofilms that may enhance its survival and persistence in chronic wounds and diabetic foot ulcers1.
Anaerococcus lactolyticus can secrete proteases that may degrade host proteins and impair wound healing.
Anaerococcus lactolyticus can modulate the inflammatory response by promoting the production of cytokines that cause inflammation, like IL-6 and IL-8, and suppressing the anti-inflammatory cytokine IL-10.
However, more research is needed to elucidate the mechanisms and factors involved in the host defenses of Anaerococcus lactolyticus and its interactions with the host immune system.
The bacteria Anaerococcus lactolyticus belongs to the Peptoniphilaceae family.
It is found in the human microbiome and is associated with various infections.
Some of the clinical manifestations of Anaerococcus lactolyticus are:
Diabetic foot and pressure ulcers: Anaerococcus lactolyticus and Anaerococcus vaginalis can be dominant species in these chronic wounds, forming biofilms and resisting antibiotic treatment.
Urinary tract infections: Anaerococcus lactolyticus can participate in polymicrobial urinary tract infections, especially in renal transplant recipients with impaired immunity and urinary catheters.
Ovarian abscesses: Anaerococcus lactolyticus can be isolated from ovarian abscesses, which are collections of pus in the ovaries caused by bacterial infection.
Knee arthritis: Anaerococcus lactolyticus can be involved in septic arthritis of the knee, which is a painful joint inflammation due to bacterial invasion.
Methods for diagnosing Anaerococcus lactolyticus include:
Culture: Grow on enriched blood agar under anaerobic conditions, forming small white colonies.
Biochemical Tests: Use kits like Rapid ID 32A or API ZYM to test for reactions like glucose fermentation and enzyme activities.
Molecular Methods: Use PCR to amplify specific DNA regions (e.g., 16S rRNA gene) or sequencing to compare DNA sequences with known bacteria. MALDI-TOF MS can analyze protein profiles for identification.
The prevention of Anaerococcus lactolyticus infections depends on the type and site of infection, as well as the individual’s risk factors and underlying conditions. However, some general measures that can be taken are:
upholding hygienic and sanitary standards, such as washing hands, cleaning wounds, and changing dressings regularly.
Avoiding or minimizing the use of foreign bodies or devices that can introduce or harbor bacteria, such as urinary catheters, intravenous lines, or prosthetic joints.
Seeking medical attention promptly if symptoms of infection occur, such as fever, pain, swelling, redness, or discharge.
Taking antibiotics as prescribed by a doctor and completing the entire course of treatment.
Following the doctor’s advice on wound care, diabetes management, or other relevant conditions affecting the healing process and the immune system.
The epidemiology of Anaerococcus lactolyticus is not very well known, but some studies have suggested that it is a common and opportunistic pathogen that can cause various infections in humans.
Some of the epidemiological aspects of Anaerococcus lactolyticus are:
Anaerococcus lactolyticus is a Gram-positive, anaerobic, saccharolytic bacterium that belongs to the family Peptoniphilaceae.
Anaerococcus lactolyticus can be found in the human body as part of the normal microbiota, especially in the skin, oral cavity, vagina, and feces.
Anaerococcus lactolyticus can also participate in polymicrobial infections of various sites, such as diabetic foot ulcers, pressure ulcers, urinary tract infections, ovarian abscesses, pleural empyema, blood infections, and soft tissue infections.
Anaerococcus lactolyticus can be isolated from clinical specimens, such as pus, blood, urine, sputum, and tissue biopsies.
Anaerococcus lactolyticus has at least two serotypes based on the presence or absence of a capsular polysaccharide antigen. The capsular antigen may influence the virulence and pathogenicity of the bacterium, as well as its susceptibility to antibiotics and host immune response.
Anaerococcus lactolyticus is generally susceptible to penicillins but resistant to tetracycline, erythromycin, and clindamycin. However, antimicrobial resistance patterns may vary depending on the geographic region and the type of infection.
Anaerococcus lactolyticus is classified as a risk group 1 bacterium according to the TRBA 466 classification, which means that it is unlikely to cause human disease or pose a hazard to workers. However, it may still cause infections in immunocompromised or debilitated individuals.
Kingdom: Bacteria
Phylum: Bacillota
Class: Clostridia
Order: Eubacteriales
Family: Peptoniphilaceae
Genus: Anaerococcus
Species: A. lactolyticus
The structure and characteristics of Anaerococcus lactolyticus can be summarized in five key points:
Gram-positive Bacterium: Anaerococcus lactolyticus possesses a thick layer of peptidoglycan in its cell wall, classifying it as a Gram-positive bacterium. Its characteristic allows it to retain the purple stain when subjected to the Gram staining method.
Strictly Anaerobic Nature: Anaerococcus lactolyticus is obligately anaerobic, meaning it can only thrive in environments devoid of oxygen. The presence of oxygen can be detrimental and potentially lethal to this bacterium.
Saccharolytic Metabolism: This bacterium is saccharolytic, indicating its ability to metabolize sugars and other carbohydrates as energy sources. Because of this metabolic activity, Anaerococcus lactolyticus produces various organic acids as by-products.
Coccal Morphology: Anaerococcus lactolyticus exhibits a coccal morphology characterized by its spherical or oval shape. Depending on the specific strain or species, it can arrange itself in pairs, tetrads, short chains, or irregular formations. The diameter of its cells typically ranges from 0.5 to 2 micrometers.
Serotypes with Capsular Antigens: Anaerococcus lactolyticus demonstrates at least two serotypes that can be distinguished based on the presence or absence of a capsular polysaccharide antigen on its surface. This capsular antigen can affect the bacterium’s virulence, pathogenicity, antibiotic susceptibility, and interaction with the host immune response.
It can be found in the human body as part of the normal microbiota. Still, it can also cause infections in various sites, such as diabetic foot ulcers, urinary tract infections, and ovarian abscesses.
The antigenic types of Anaerococcus lactolyticus need to be well-studied. Still, some research has suggested that it has at least two serotypes based on the presence or absence of a capsular polysaccharide antigen. The capsular antigen may play a role in the virulence and pathogenicity of this bacterium, as well as its susceptibility to antibiotics and host immune response. However, more studies are needed to confirm and characterize the antigenic types of Anaerococcus lactolyticus and their clinical significance.
The pathogenesis of Anaerococcus lactolyticus is not well understood, but some possible mechanisms have been suggested based on its characteristics and associations with various infections. Here are some of them:
Anaerococcus lactolyticus is a saccharolytic bacterium that can ferment glucose and other carbohydrates to produce lactic acid and other organic acids.
Because of these acids, the pH of the local environment creates favorable conditions for the growth of other anaerobic bacteria, such as Peptoniphilus, Finegoldia, and Prevotella.
It can lead to polymicrobial infections and biofilm formation, impairing wound healing and increasing antibiotic resistance.
Anaerococcus lactolyticus can also produce hydrogen sulfide, a toxic gas that can damage the host tissues and cells. Hydrogen sulfide can also inhibit the oxidative burst of neutrophils, which are critical immune cells that kill bacteria. It can impair the host’s defense against infection and inflammation.
Anaerococcus lactolyticus can adhere to epithelial proteins in the extracellular matrix, which includes fibronectin and collagen, and cells involved in tissue repair and integrity. It can facilitate its invasion and colonization of the host tissues, especially in the presence of foreign bodies or damaged surfaces.
Anaerococcus lactolyticus can trigger inflammatory responses in the host by activating toll-like receptors (TLRs), which recognize bacterial components and initiate immune signaling pathways. It can produce Interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha), two pro-inflammatory cytokines, which can cause tissue damage and systemic symptoms.
The host defenses of Anaerococcus lactolyticus are poorly understood, but some studies have suggested that the bacterium can evade or resist the immune system in various ways. For example:
Anaerococcus lactolyticus can produce a capsular polysaccharide antigen that may protect it from phagocytosis and complement-mediated killing.
Anaerococcus lactolyticus can form biofilms that may enhance its survival and persistence in chronic wounds and diabetic foot ulcers1.
Anaerococcus lactolyticus can secrete proteases that may degrade host proteins and impair wound healing.
Anaerococcus lactolyticus can modulate the inflammatory response by promoting the production of cytokines that cause inflammation, like IL-6 and IL-8, and suppressing the anti-inflammatory cytokine IL-10.
However, more research is needed to elucidate the mechanisms and factors involved in the host defenses of Anaerococcus lactolyticus and its interactions with the host immune system.
The bacteria Anaerococcus lactolyticus belongs to the Peptoniphilaceae family.
It is found in the human microbiome and is associated with various infections.
Some of the clinical manifestations of Anaerococcus lactolyticus are:
Diabetic foot and pressure ulcers: Anaerococcus lactolyticus and Anaerococcus vaginalis can be dominant species in these chronic wounds, forming biofilms and resisting antibiotic treatment.
Urinary tract infections: Anaerococcus lactolyticus can participate in polymicrobial urinary tract infections, especially in renal transplant recipients with impaired immunity and urinary catheters.
Ovarian abscesses: Anaerococcus lactolyticus can be isolated from ovarian abscesses, which are collections of pus in the ovaries caused by bacterial infection.
Knee arthritis: Anaerococcus lactolyticus can be involved in septic arthritis of the knee, which is a painful joint inflammation due to bacterial invasion.
Methods for diagnosing Anaerococcus lactolyticus include:
Culture: Grow on enriched blood agar under anaerobic conditions, forming small white colonies.
Biochemical Tests: Use kits like Rapid ID 32A or API ZYM to test for reactions like glucose fermentation and enzyme activities.
Molecular Methods: Use PCR to amplify specific DNA regions (e.g., 16S rRNA gene) or sequencing to compare DNA sequences with known bacteria. MALDI-TOF MS can analyze protein profiles for identification.
The prevention of Anaerococcus lactolyticus infections depends on the type and site of infection, as well as the individual’s risk factors and underlying conditions. However, some general measures that can be taken are:
upholding hygienic and sanitary standards, such as washing hands, cleaning wounds, and changing dressings regularly.
Avoiding or minimizing the use of foreign bodies or devices that can introduce or harbor bacteria, such as urinary catheters, intravenous lines, or prosthetic joints.
Seeking medical attention promptly if symptoms of infection occur, such as fever, pain, swelling, redness, or discharge.
Taking antibiotics as prescribed by a doctor and completing the entire course of treatment.
Following the doctor’s advice on wound care, diabetes management, or other relevant conditions affecting the healing process and the immune system.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
